The Trentonian (Trenton, NJ)

Health officials worry nation not ready for vaccine

- Kaiser Health News

Millions of Americans are counting on a COVID-19 vaccine to curb the global pandemic and return life to normal.

While one or more options could be available toward the end of this year or early next, the path to delivering vaccines to 330 million people remains unclear for the local health officials expected to carry out the work.

“We haven’t gotten a lot of informatio­n about how this is going to roll out,” said Dr. Umair Shah, executive director of the public health department in Harris, Texas.

The Centers for Disease Control and Prevention has told local health department­s to draft vaccinatio­n plans by Oct. 1 “to coincide with the earliest possible release of COVID-19 vaccine.”

But health department­s that have been underfunde­d for decades say they lack the staff, money and tools to educate people about vaccines and then to distribute, administer and track hundreds of millions of doses. Nor do they know when, or if, they will get federal aid to do that.

Dozens of doctors, nurses and health officials interviewe­d by Kaiser Health News and The Associated Press expressed concern about the country’s readiness to conduct mass vaccinatio­ns, as well as frustratio­n with months of inconsiste­nt informatio­n from the federal government.

The gaps include figuring out how officials will keep track of who has gotten which doses and how they will keep the workers who give the shots safe, with enough protective gear and syringes to do their jobs.

With only about half of Americans saying they would get vaccinated, according to a poll from APNORC Center for Public Affairs Research, it also will be crucial to educate people about the benefits of vaccinatio­n, said Molly Howell, who manages the North Dakota Department of Health’s immunizati­on program.

The U.S. has committed more than $10 billion to develop new coronaviru­s vaccines but hasn’t allocated money specifical­ly for distributi­ng and administer­ing them.

And while local government­s received billions in congressio­nal emergency funding, that money is not earmarked for distributi­ng a vaccine.

An ongoing investigat­ion by KHN and the AP has detailed how state and local public health department­s across the U.S. have been starved for decades, leaving them underfunde­d and without adequate resources to confront the coronaviru­s pandemic. The investigat­ion further found that federal coronaviru­s funds have been slow to reach public health department­s, forcing some communitie­s to cancel essential services.

States are allowed to use some of the federal money they have already received to prepare for immunizati­ons. But AP and KHN found that many health department­s are so overwhelme­d with the current costs of the pandemic, such as for testing and contact tracing, that they can’t reserve money for the vaccine work to come. Health department­s will need to hire people to administer the vaccines and systems to track them, and pay for supplies such as protective medical masks, gowns and gloves, as well as warehouses and refrigerat­or space.

Pima County, Ariz., is already at least $30 million short of what health officials need to fight the pandemic, let alone plan for vaccines, said Dr. Francisco Garcia, deputy county administra­tor and chief medical officer.

Some federal funds will expire soon. The $150 billion that states and local government­s received from a fund in the CARES Act, for example, covers only expenses made through the end of the year, said Gretchen Musicant, health commission­er in Minneapoli­s. That is a problem, given vaccine distributi­on may not have even begun.

Although public health officials say they need help, Congress left Washington for its summer recess without passing a new pandemic relief bill that would include additional funding for vaccine distributi­on.

States can’t just use the existing funding sources to attempt the largest vaccinatio­n campaign in history, said Dr. Kelly Moore of the Immunizati­on Action Coalition, a national vaccine education and advocacy organizati­on.

Then there’s the basic question of scale. Last winter, the country distribute­d 175 million vaccines for seasonal influenza vaccine, according to the Centers for Disease Control and Prevention.

But for the U.S. to reach herd immunity to the coronaviru­s, most experts say, the nation would likely need to vaccinate roughly 70% of Americans, or 200 million people. The first vaccines will require two doses to be effective, or 400 million shots.

Experts expect many public health department­s to struggle to adequately track who has been vaccinated and when, because a lack of funding in recent decades has left them in the technologi­cal dark ages.

Moore, the medical director of Tennessee’s immunizati­on plan during the H1N1 influenza pandemic, said people will need to receive their second COVID-19 dose 21 or 28 days after the first, so health providers will need to remind patients to receive their second shot. They also will need to ensure that the second dose is the same brand as the first.

She expects many states to face major challenges as they try to account for and report on immunizati­ons down to the dose, which the CDC is requiring.

The CDC is developing an app called the Vaccine Administra­tion Monitoring System for health department­s whose data systems lag, said Claire Hannan, executive director of the Associatio­n of Immunizati­on Managers.

Meanwhile, health department­s are dealing with vaccine registries that sometimes date to the late 1980s.

Overwhelme­d public health teams are already working long hours to test patients and trace their contacts, the time-consuming process that will need to continue even after vaccines become available. When that happens, health department­s will need more staffers for a range of work, including educating the public, monitoring patients and reporting serious side effects.

At an August meeting about vaccine distributi­on, Dr. Ngozi Ezike, director of Illinois’ health department, said her state will need to recruit additional health profession­als to administer the shots, including nursing students, medical students, dentists, dental hygienists and even veterinari­ans. Such vaccinator­s will need medical-grade masks, gowns and gloves to keep them safe.

Given that vaccines are far more complex than personal protective equipment and other medical supplies — one vaccine candidate must be stored at minus 94 degrees — Dr. Marcus Plescia, chief medical officer at the Associatio­n of State and Territoria­l Health Officials, said people should be prepared for shortages, delays and mix-ups.

“It’s probably going to be even worse than the problems with testing and PPE,” Plescia said.

 ?? TED S. WARREN — THE ASSOCIATED PRESS ?? Vials used by pharmacist­s to prepare syringes were used in Seattle on March 16, the first day of a clinical trial of a potential vaccine for COVID-19.
TED S. WARREN — THE ASSOCIATED PRESS Vials used by pharmacist­s to prepare syringes were used in Seattle on March 16, the first day of a clinical trial of a potential vaccine for COVID-19.

Newspapers in English

Newspapers from United States